Manufactura De Fibras Sinteticas - Mafisa SA - Company Review
Manufactura De Fibras Sinteticas - Mafisa SA - Company ReviewSummary
Manufactura De Fibras Sinteticas - Mafisa SA (MAFISSA), formerly Petroquimica Sudamericana is a chemical company that offers production of synthetic yarns and fibres. The company produces polymers, synthetic polyester, polyethylene terephthalate and fibres. It provides Ma-Fix Fibers for concrete. MAFISSA provides products such as chips, POY yarns, textured yarns and fibres. The company’s products are used in the manufacturing of clothes such as jackets, towels, curtains, shirts, trousers, sheets and pillows. It process its products into fabrics and clothes. The company serves Argentinian and Mercosur markets. It operates through its plant located in Lisandro Olmos. MAFISSA is headquartered in Buenos Aires, Argentina.
This comprehensive company report of Manufactura De Fibras Sinteticas - Mafisa SA provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.